- E-post
- inger.loes@uib.no
- Besøksadresse
-
Haukeland universitetssykehus, Laboratoriebygget
5009 Bergen - Postadresse
-
Postboks 7804
5020 Bergen
Forskning
Tilknyttet Mohn Kreftforskningslaboratorium som postdoktor.
Publikasjoner
Vitenskapelig artikkel
- Johanna Austrheim Hundvin; Jonas Habrich; Cihan Gani et al. (2025). Early response prediction during radiotherapy in rectal cancer using sequential diffusion-weighted imaging at a magnetic resonance image-guided linear accelerator. (ekstern lenke)
- Kazunari Sasaki; Johan Gagnière; Aurélien Dupré et al. (2021). Performance of two prognostic scores that incorporate genetic information to predict long-term outcomes following resection of colorectal cancer liver metastases: An external validation of the MD Anderson and JHH-MSK scores. (ekstern lenke)
- Randi Skår; Inger Marie Løes; Lise Thorsen et al. (2010). Cytostatika og oral helse. (ekstern lenke)
- Georgios A. Margonis; Thomas Boerner; Jean-Baptiste Bachet et al. (2023). Demystifying BRAF Mutation Status in Colorectal Liver Metastases: A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions. (ekstern lenke)
- Dimitris Bertsimas; Georgios Antonios Margonis; Suleeporn Sujichantararat et al. (2022). Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver Metastases. (ekstern lenke)
- Jon-Helge Angelsen; Asgaut Viste; Inger Marie Løes et al. (2015). Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases. (ekstern lenke)
- Pim B. Olthof; Stefan Buettner; Nikolaos Andreatos et al. (2022). KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations. (ekstern lenke)
- Georgios Antonios Margonis; Stefan Buettner; Nikolaos Andreatos et al. (2019). Prognostic factors change over time after hepatectomy for colorectal liver metastases: A multi-institutional, international analysis of 1099 patients. (ekstern lenke)
- Jon-Helge Angelsen; Arild Horn; Halfdan Sorbye et al. (2017). Population-based study on resection rates and survival in patients with colorectal liver metastasis in Norway. (ekstern lenke)
- Inger Marie Løes; Heike Immervoll; Halfdan Sorbye et al. (2016). Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases. (ekstern lenke)
- Georgios Antonios Margonis; Stefan Buettner; Nikolaos Andreatos et al. (2018). Association of BRAF mutations with survival and recurrence in surgically treated patients with metastatic colorectal liver cancer. (ekstern lenke)
- Johanna Austrheim Hundvin; Unn Hege Lilleøren; Alexander Valdman et al. (2024). Comparing robust proton versus online adaptive photon radiotherapy for short-course treatment of rectal cancer. (ekstern lenke)
- Kazunari Sasaki; Jane Wang; Carsten Kamphues et al. (2024). Evaluating Combinations of Biological and Clinicopathologic Factors Linked to Poor Outcomes in Resected Colorectal Liver Metastasis: An External Validation Study. (ekstern lenke)
- Inger Marie Løes; Heike Immervoll; Jon-Helge Angelsen et al. (2015). Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimen. (ekstern lenke)
- Olav Dahl; Mette Pernille Myklebust; Jon Espen Dale et al. (2020). Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version. (ekstern lenke)
- Anita Sveen; Inger Marie Løes; Sharmini Alagaratnam et al. (2016). Intra-patient inter-metastatic genetic heterogeneity in colorectal cancer as a key determinant of survival after curative liver resection. (ekstern lenke)
- Carsten Kamphues; Nikolaos Andreatos; Jochen Kruppa et al. (2021). The optimal cut-off values for tumor size, number of lesions, and CEA levels in patients with surgically treated colorectal cancer liver metastases: An international, multi-institutional study. (ekstern lenke)
- Georgios Antonios Margonis; Neda Amini; Stefan Buettner et al. (2021). The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status: A Study By the International Genetic Consortium for Colorectal Liver Metastasis. (ekstern lenke)
- Neda Amini; Nikolaos Andreatos; Georgios Antonios Margonis et al. (2021). Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?. (ekstern lenke)
- Amar Deshwar; Georgios Antonios Margonis; Nikolaos Andreatos et al. (2018). Double KRAS and BRAF mutations in surgically treated colorectal cancer liver metastases: An international, multi-institutional case series. (ekstern lenke)
- Georgios Antonios Margonis; Jaeyun Jane Wang; Thomas Boerner et al. (2024). Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study. (ekstern lenke)